Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Summit Therapeutics Inc. | 3,073,603 | reported | 21 Oct 2025 | tx 11+32,341,049 |
| PULSE BIOSCIENCES, INC. | 30,000 | reported | 15 Aug 2025 | tx 13+558,885 |
| ALNYLAM PHARMACEUTICALS, INC. | 20,000 | reported | 28 Feb 2019 | tx 8+54,021 |
| ARENA PHARMACEUTICALS INC | 5,902 | reported | 17 Jun 2020 | tx 12+23,750−2,848 |
| PHARMACYCLICS INC | 0 | reported | 26 May 2015 | tx 30+153,709−203,971 |
| REATA PHARMACEUTICALS INC | 0 | reported | 26 Sept 2023 | tx 44+942,988−942,988 |
| ARIAD PHARMACEUTICALS INC | 0 | reported | 16 Feb 2017 | tx 5+557,937−561,210 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 Oct 2025 | GRANT_AWARD | Summit Therapeutics Inc. | 53,361 | 18.74 USD | |
| 15 Aug 2025 | GRANT_AWARD | PULSE BIOSCIENCES, INC. | 30,000 | 0.00 USD | deriv |
| 29 Apr 2025 | GRANT_AWARD | Summit Therapeutics Inc. | 11,200,000 | — | deriv |
| 11 Sept 2024 | GRANT_AWARD | Summit Therapeutics Inc. | 44,052 | 22.70 USD | |
| 23 Aug 2024 | GRANT_AWARD | Summit Therapeutics Inc. | 2,800,000 | — | deriv |
| 09 Aug 2024 | GRANT_AWARD | PULSE BIOSCIENCES, INC. | 200,000 | 0.00 USD | deriv |
| 06 Jun 2024 | GRANT_AWARD | PULSE BIOSCIENCES, INC. | 20,000 | 0.00 USD | deriv |
| 02 Apr 2024 | GRANT_AWARD | Summit Therapeutics Inc. | 1,100,000 | — | deriv |
| 13 Oct 2023 | PURCHASE | Summit Therapeutics Inc. | 2,976,190 | 1.68 USD | first after silence |
| 13 Oct 2023 | GRANT_AWARD | Summit Therapeutics Inc. | 14,000,000 | — | deriv |
| 26 Sept 2023 | OTHER | REATA PHARMACEUTICALS INC | 62,621 | — | |
| 26 Sept 2023 | OTHER | REATA PHARMACEUTICALS INC | 95,475 | — | deriv |
| 26 Sept 2023 | OTHER | REATA PHARMACEUTICALS INC | 75,000 | — | deriv |
| 26 Sept 2023 | OTHER | REATA PHARMACEUTICALS INC | 175,000 | — | deriv |
| 26 Sept 2023 | OTHER | REATA PHARMACEUTICALS INC | 50,000 | — | deriv |
| 26 Sept 2023 | OTHER | REATA PHARMACEUTICALS INC | 75,000 | — | deriv |
| 26 Sept 2023 | OTHER | REATA PHARMACEUTICALS INC | 24,000 | — | deriv |
| 26 Sept 2023 | OTHER | REATA PHARMACEUTICALS INC | 25,000 | — | deriv |
| 16 Aug 2023 | SALE | REATA PHARMACEUTICALS INC | 1,755 | 168.41 USD | |
| 28 Jul 2023 | CONVERSION | REATA PHARMACEUTICALS INC | 75,000 | — | |
| 28 Jul 2023 | SALE | REATA PHARMACEUTICALS INC | 75,000 | 164.62 USD | |
| 28 Jul 2023 | EXERCISE | REATA PHARMACEUTICALS INC | 75,000 | 0.00 USD | deriv |
| 28 Jul 2023 | CONVERSION | REATA PHARMACEUTICALS INC | 75,000 | — | deriv |
| 28 Jul 2023 | EXERCISE | REATA PHARMACEUTICALS INC | 75,000 | 72.70 USD | deriv |
| 06 Jul 2023 | GRANT_AWARD | REATA PHARMACEUTICALS INC | 6,000 | 0.00 USD |
2 purchases reported after at least 12 months of silence — most recent on 13 Oct 2023.